Category
6 articles
The most hands-on investor in your round might also be the most dangerous one. Here's how over-involved angels quietly capture early-stage companies — and the boundary-setting scripts to use before the money hits your account.
The 'team risk' objection often lands before you've pitched anything at all. A look at when the solo-founder bias is legitimate, when it's a lazy excuse, and how successful solo founders fight back.
Spray-and-pray fundraising feels productive, but it's quietly torching your round. A look at why volume kills momentum — and how a tight, sequenced list of 20 real targets outperforms a thousand cold emails every time.
Most bridge rounds are built for the investors writing them, not the founders signing them. Here's how bridges go wrong — PETS, ratchets, crowding out — and how to decide whether you should bridge at all.
The checks you raise from angels feel friendly until a Series A diligence team reads the docs. We tore down three anonymized early rounds to show how side letters, pro-rata promises, and quirky liquidation preferences ripple into institutional rounds — and built the checklist to run before you sign anything.
SAFEs feel free until you run the dilution math. We compared recent US pre-seed structures and found founders routinely giving up 2-4 extra points for speed. Here's when simplicity is worth it — and when it absolutely isn't.